Premium
Tocilizumab administration in patients with SARS‐CoV‐2 infection: Subcutaneous injection vs intravenous infusion
Author(s) -
Shabani Minoosh,
Shokouhi Shervin,
Moradi Omid,
Saffaei Ali,
Sahraei Zahra
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26124
Subject(s) - tocilizumab , medicine , cytokine release syndrome , subcutaneous injection , cytokine storm , pharmacokinetics , interquartile range , route of administration , pharmacology , covid-19 , rheumatoid arthritis , disease , infectious disease (medical specialty)